title: Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
authors.forename: Wing-Yan
authors.initials: WY
authors.lastname: Au
authors.forename: Cyrus R
authors.initials: CR
authors.lastname: Kumana
authors.forename: Maybelle
authors.initials: M
authors.lastname: Kou
authors.forename: Raymond
authors.initials: R
authors.lastname: Mak
authors.forename: Godfrey C F
authors.initials: GC
authors.lastname: Chan
authors.forename: Ching-Wan
authors.initials: CW
authors.lastname: Lam
authors.forename: Yok-Lam
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage*; D012074:Remission Induction; D016879:Salvage Therapy; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use
chemical_list: D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide